Whole Exome Sequencing Market Is Anticipated To Grow Up To USD 7.4 Billion By 2032 | Boston Scientific, QIAGEN, OraSure Technologies

The global Whole Exome Sequencing Market was valued at USD 1.4 Billion in 2022 and it is anticipated to grow up to USD 7.4 Billion by 2032, at a CAGR of 18.1% during the forecast period.

Exome sequencing is a method for sequencing a genomes whole-exome and protein-coding genes. This method entails selecting the DNA segments that code for proteins or exons, then sequencing the exonic DNA with high-throughput DNA sequencing technologies. Exome sequencing is a technique for identifying genetic variations that cause disorders like Miller Syndrome and Alzheimers disease.

Request free sample copy of this research study: https://www.globalinsightservices.com/request-sample/GIS10515

Market Trends and Drivers

The rising applications in clinical diagnostics, high demand for the diagnosis of rare diseases, expanding R&D in the field of genomics, next-generation sequencing, and increasing need for customized medicine are the key factors driving the global Whole Exome Sequencing Market. The total market is being driven by growth in the acceptability of next-generation sequencing approaches for the prediction, treatment, and monitoring of a variety of chronic diseases, such as cancer. The total market is being driven by growth in the acceptability of next-generation sequencing approaches for the prediction, treatment, and monitoring of a variety of chronic diseases, such as cancer. Some of the primary driving reasons for the worldwide Whole Exome Sequencing Market include the cheap costs and increased speed associated with whole-exome sequencing techniques, technological improvements in whole-exome sequencing techniques, and global partnerships among prominent research institutes..

Major Players in the Global Whole Exome Sequencing Market

The key players in the Whole Exome Sequencing Market are Ambry Genetics Corp. Bio-Rad Laboratories Inc., Eurofins Scientific Group, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Boston Scientific Corporation, QIAGEN, OraSure Technologies, Inc., Thermo Fisher Scientific, Helix OpCo, LLC., among others.

COVID-19 Impact:

The outbreak of the COVID-19 pandemic pushed the pharmaceutical industry into action, with a race to develop therapeutic and preventive interventions. The onset of the SARS-CoV-2 pandemic set many pharmaceutical companies to quickly add clinical sequencing to expand safety testing that helped fight against the COVID-19 pandemic. COVID-19 had a significant impact on the whole exome sequencing market. For instance, as per the study published in PLOS ONE in January 2022, it was concluded that COVID-19 syndrome caused significant alterations in the blood transcriptome, which were assessed using RNAseq and verified using digital droplet PCR (ddPCR) on specific targets. Such studies augment the use of whole exome sequencing in analyzing the progression of COVID-19, thereby boosting the market's growth over the coming years. Hence, owing to the increasing RNA and DNA sequencing-based research & development activities in developing diagnostic tools or effective therapeutics for COVID-19, the market is likely to continue its significant growth rate during the forecast period.

Speak to Analyst for more details:  https://www.globalinsightservices.com/request-customization/GIS10515

Global Whole Exome Sequencing Market Segmentation

By Product

System
Kits
Services

By Technology

Second-Generation Sequencing
Third-Generation Sequencing

By Application

Diagnostics
Drug Discovery and Development
Personalized Medicine
Others

Purchase your copy now: https://www.globalinsightservices.com/checkout/single_user/GIS10515

With Global Insight Services, you receive:

10-year forecast to help you make strategic decisions
In-depth segmentation which can be customized as per your requirements
Free consultation with lead analyst of the report
Excel data pack included with all report purchases
Robust and transparent research methodology

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/

This release was published on openPR.